Cue Applies for EUA for Flu + COVID-19 Molecular Test
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Covid 19, Flu & Respiratory Infections, Molecular Diagnostic Analyzers, POC Rapid Assays |
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Chris Wolski | Sep 28, 2022 | Diagnostic Technologies |
Molex has released the results of a global survey identifying market drivers impacting the development of diagnostic wearables.
Read MorePosted by Chris Wolski | Sep 27, 2022 | Cancer, Molecular Diagnostic Analyzers |
UCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
Read MorePosted by Chris Wolski | Sep 22, 2022 | Education, Lab Management |
Due to a number of factors, including, a lack of training programs, there is a severe shortage of clinical laboratory technicians.
Read MorePosted by Andy Lundin | Sep 21, 2022 | Company News, Diagnostic Technologies |
BrightInsight and bioMérieux announced a partnership to develop and bring to market a Clinical Digital Solution for diagnostics.
Read More